Guidelines on the use of extracorporeal photopheresis

R Knobler, G Berlin, P Calzavara‐Pinton… - Journal of the …, 2014 - Wiley Online Library
Background After the first investigational study on the use of extracorporeal photopheresis
for the treatment of cutaneous T‐cell lymphoma was published in 1983 with its subsequent …

Cellular regulation of the inflammatory response

WJ Janssen, PM Henson - Toxicologic pathology, 2012 - journals.sagepub.com
In simple terms, inflammation can be defined as a beneficial, nonspecific response of tissues
to injury that generally leads to restoration of normal structure and function. In this concept …

Systematic review and meta-analysis of prospective studies for ECP treatment in patients with steroid-refractory acute GVHD

H Zhang, R Chen, J Cheng, N Jin… - Patient preference and …, 2015 - Taylor & Francis
Purpose The aim of this systematic review was to evaluate the efficacy and safety of
extracorporeal photopheresis (ECP) treatment in patients with steroid-refractory acute graft …

European dermatology forum: Updated guidelines on the use of extracorporeal photopheresis 2020–Part 2

R Knobler, P Arenberger, A Arun… - Journal of the …, 2021 - Wiley Online Library
Background Following the first investigational study on the use of extracorporeal
photopheresis for the treatment of cutaneous T‐cell lymphoma published in 1983, this …

Cyclosporine and extracorporeal photopheresis are equipotent in treating severe atopic dermatitis: a randomized cross-over study comparing two efficient treatment …

U Koppelhus, J Poulsen, N Grunnet… - Frontiers in …, 2014 - frontiersin.org
Background: Severe atopic dermatitis (AD) is a recurrent and debilitating disease often
requiring systemic immunosuppressive treatment. The efficacy of cyclosporine A (CsA) is …

Cutaneous T cell lymphoma: update on treatment

U Wollina - International journal of dermatology, 2012 - Wiley Online Library
Background Cutaneous T‐cell lymphoma (CTCL) is a myeloproliferative disease with
pronounced epidermotropism. The major subtypes of CTCL are mycosis fungoides and …

Immunosuppressive therapy in allograft transplantation: from novel insights and strategies to tolerance and challenges

A Ebrahimi, SA Hosseini, F Rahim - Central European Journal of …, 2014 - termedia.pl
Abstract immunosuppression therapy is the key to successful post-transplantation outcomes.
The need for ideal immunosuppression became durable maintenance of long-term graft …

Phototherapy and photopheresis: old and new indications

F Osório, S Magina - Expert Review of Dermatology, 2011 - Taylor & Francis
The benefit of UV light in the treatment of skin disorders has been known for decades, but
new discoveries have been made throughout the years since its first use, including new …

Apheresis in the treatment of recalcitrant atopic dermatitis: case series and review of the literature

A Chiricozzi, S Faleri, A Lanti, G Adorno, B Lorè… - European Journal of …, 2014 - Springer
Background Atopic dermatitis is a chronic disabling inflammatory skin disorder, typically
characterized by intensely itching, oozing, crusted, eroded vesicles or papules developing …

Persistent complete molecular remission after nilotinib and graft-versus-leukemia effect in an acute lymphoblastic leukemia patient with cytogenetic relapse after …

P Farnsworth, D Ward, V Reddy - Experimental Hematology & Oncology, 2012 - Springer
We report the successful treatment and sustained molecular remission using single agent
nilotinib in a relapsed Philadelphia chromosome positive (Ph+) acute lymphoblastic …